Gynecomastia (Male Chest) | Medicines and Non-Surgical Treatments

In medical literature, selective estrogen receptor modulators like tamoxifen and raloxifene have been evaluated for symptomatic pubertal or idiopathic breast swelling before irreversible fibrosis develops. Studies report partial nodule regression in selected cohorts during early stages. However, double-blind crossover trials observed only modest benefits over placebo, and medications prove ineffective once mature fibrous tissue forms. In his Jaipur practice, Dr. Vishal Purohit does not prescribe medications for gynecomastia. He notes that pubertal gynecomastia does not need medical therapy, whereas persistent glandular enlargement is resolved definitively with surgical excision. Crucially, once the glandular tissue is removed surgically, it cannot grow back.

Adolescent physiologic gynecomastia typically resolves on its own within six months to two years, making initial observation the standard clinical approach. Medical evaluation is indicated if symptoms persist past two years or after seventeen years of age to rule out contributing medications or underlying illness. Published literature mentions estrogen receptor modulators or testosterone if no secondary cause is identified and the patient seeks non-surgical intervention. In Dr. Purohit's clinical practice, however, medicines are not prescribed for gynecomastia because pubertal enlargement does not require medication, and surgical excision removes glandular tissue permanently.

Male breast enlargement, known as gynecomastia, involves the proliferation of gland ducts and stromal components, including fat. Published medical records do not provide evidence on dosing, duration, efficacy rates, or safety outcomes for using aromatase inhibitors like anastrozole or letrozole to dissolve established breast tissue. In his clinical practice, Dr. Vishal Purohit does not prescribe medicines for gynecomastia, explaining that pubertal gynecomastia does not need medication and established glandular tissue does not resolve with tablets. Instead, definitive correction of excess male breast tissue is achieved surgically through liposuction combined with sharp gland excision, ensuring that once the gland is removed, it cannot grow back.

Gynecomastia is the most common form of male breast alteration, physiologically driven by the proliferation of gland ducts and stromal components, including fat. While modifying causative medications, addressing underlying systemic conditions, or managing early hormonal fluctuations can address initial breast tissue development, established anatomical proliferation cannot be excised pharmacologically. Published reports emphasize that surgical correction is specifically indicated when medical treatments fail. Once breast tissue has transitioned into chronic, stable structural enlargement, ongoing medical therapy cannot reduce the accumulated glandular and stromal volume. Consequently, definitive resolution of established gynecomastia requires surgical intervention to directly excise excess tissue rather than relying on ineffective medication trials.

Gynecomastia stems from an imbalance between testosterone and estrogen, where estrogen stimulates breast gland growth and testosterone counteracts it. Published medical literature notes that true gynecomastia consists of dense, firm glandular tissue mixed with softer fatty deposits, whereas pseudogynecomastia involves localized fat accumulation alone. Exercising or losing weight does not eliminate firm glandular tissue. While prescribed testosterone replacement has a recognized role in treating selected older males diagnosed with low testosterone levels, non-prescription supplements lack medical justification for breast gland reduction. In Dr. Vishal Purohit's clinical view, creams, Ayurvedic or herbal products, and home remedies are useless and a waste of time and money. Furthermore, unregulated supplements can trigger hormonal disruptions.